Related Experiment Videos
Erythromycin-induced clozapine toxic reaction
L G Cohen1, S Chesley, L Eugenio
1Department of Pharmacy Practice, Bouve College of Pharmacy, Northeastern University, Boston, Mass, USA.
Archives of Internal Medicine
|March 25, 1996
Summary
Erythromycin can increase clozapine levels, leading to adverse effects in schizophrenia patients. This case highlights the importance of monitoring drug interactions during clozapine therapy.
Area of Science:
- Pharmacology
- Neuroscience
- Clinical Toxicology
Background:
- Clozapine is an atypical antipsychotic used for treatment-resistant schizophrenia.
- It is metabolized by hepatic microsomal enzymes, making it susceptible to drug interactions.
- Drug interactions can alter clozapine serum concentrations, affecting efficacy and safety.
Observation:
- A 34-year-old male patient with schizophrenia experienced adverse effects while on clozapine therapy.
- The patient was concurrently treated with erythromycin for a lower respiratory tract infection.
- This led to elevated clozapine serum concentrations, leukocytosis, and significant side effects.
Findings:
- Concomitant erythromycin therapy resulted in increased clozapine serum concentrations.
- The patient exhibited symptoms of clozapine toxicity, including somnolence, impaired coordination, slurred speech, disorientation, and incontinence.
- Discontinuation of both clozapine and erythromycin, followed by gradual reintroduction of clozapine, resolved the adverse effects.
Implications:
- Clinicians must be aware of potential interactions between clozapine and erythromycin.
- Monitoring clozapine serum concentrations and for adverse effects is crucial when initiating erythromycin.
- This case underscores the clinical significance of drug-metabolizing enzyme interactions in managing schizophrenia with clozapine.